Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2190-2196

  Metso, Saara ^a,b   Jaatinen, Pia ^a,b   Huhtala, Heini ^a,c   Auvinen, Anssi ^c,d   Oksala, Heikki ^a   Salmi, Jorma ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THYROID DISEASE; UNIVERSITY HOSPITAL;

EID: 34347267317     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2321     Document Type: Article

References (25)

1. Franklyn JA 1994 The management of hyperthyroidism. N Engl J Med 330:1731-1738
2. Rivkees SA, Sklar C, Freemark M 1998 Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776
3. Hoffman DA, McConahey WM, Diamond EL, Kurland LT 1982 Mortality in women treated for hyperthyroidism. Am J Epidemiol 115:243-254
4. Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS, Ridgway EC 1988 Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. Am J Epidemiol 127:969-980
5. Goldman MB, Monson RR, Maloof F 1990 Cancer mortality in women with thyroid disease. Cancer Res 50:2283-2289
6. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris III BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280:347-355
7. Hall P, Berg G, Bjelkengren G, Boice Jr JD, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J, Wiklund K 1992 Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 50:886-890
8. Hall P, Lundell G, Holm LE 1993 Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 128:230-234
9. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P 1998 Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712-718
10. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353:2111-2115
11. Franklyn JA, Sheppard MC, Maisonneuve P 2005 Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 294:71-80
12. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164
13. Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J 2004 Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 61:641-648
14. Osman F, Gammage MD, Sheppard MC, Franklyn JA 2002 Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace? J Clin Endocrinol Metab 87:963-967
15. Osman F, Gammage MD, Franklyn JA 2002 Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 12:483-487
16. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
17. Mahonen M, Salomaa V, Torppa J, Miettinen H, Pyorala K, Immonen-Raiha P, Niemela M, Ketonen M, Arstila M, Kaarsalo E, Lehto S, Mustaniemi H, Palomaki P, Puska P, Vuorenmaa T, Tuomilehto J 1999 The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983-1992. Finnish multinational monitoring of trends and determinants in cardiovascular disease. J Clin Epidemiol 52:157-166
18. Leppala JM, Virtamo J, Heinonen OP 1999 Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol 15:155-160
19. Lahti RA, Penttila A 2001 The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Sci Int 115:15-32
20. Lahti RA, Penttila A 2003 Cause-of-death query in validation of death certification by expert panel; effects on mortality statistics in Finland, 1995. Forensic Sci Int 131:113-124
21. Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG 1991 Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83:1072-1077
22. Edmonds CJ, Smith T 1986 The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59:45-51
23. Hoffman DA, McConahey WM, Fraumeni Jr JF, Kurland LT 1982 Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 11:218-224
24. UNSCEAR 2000 Report. Vol. II. United Nations Scientific Committee on Effects of Atomic Radiation. Epidemiological evaluation of radiation-induced cancer. New York; United Nations
25. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444